Concepedia

Eduardo Dunayevich

ED

Statistics

Publications

36

Citations

5.6K

H-Index

31

Active since

1995

Affiliations

VistaGen Therapeutics (United States)(Current)

University of Cincinnati Medical Center

Eli Lilly (United States)

Amgen (United States)

University of Maryland, Baltimore

Eduardo Dunayevich is an author at VistaGen Therapeutics (United States) specializing in medicine, psychopharmacology, and pharmacotherapy.

Publications per year

1995–2024

36

Publications

36

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Frank L. Greenway, Ken Fujioka, Raymond A Plodkowski et al. · The Lancet · 2010 · 1K citations

, , +11

A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II)

Caroline M. Apovian, Louis J. Aronne, Domenica Rubino et al. · Obesity · 2013 · 711 citations · Full text

, , +15

Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR‐BMOD Trial

Thomas A. Wadden, John P. Foreyt, Gary D. Foster et al. · Obesity · 2010 · 553 citations · Full text

, , +14

Rational Design of a Combination Medication for the Treatment of Obesity

Frank L. Greenway, M.J. Whitehouse, Maria Guttadauria et al. · Obesity · 2008 · 345 citations · Full text

, , +17

Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial

James T. Hartford, Susan G. Kornstein, Michael R. Liebowitz et al. · International Clinical Psychopharmacology · 2007 · 287 citations

, , +17

1–5 of 36